Loading...
Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder resulting from a polyglutamine expansion in the huntingtin (HTT) protein. There is currently no cure for this disease, but recent studies suggest that RNAi to downregulate the expression of both normal and mutant HTT is a...
Saved in:
| Published in: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Gene & Cell Therapy
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5453866/ https://ncbi.nlm.nih.gov/pubmed/28603746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2017.05.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|